-
1
-
-
26444504833
-
Transfusion management in sickle cell disease
-
Wanko SO, Telen MJ. Transfusion management in sickle cell disease. Hematol Oncol Clin N Am 2005;19:803-26.
-
(2005)
Hematol Oncol Clin N Am
, vol.19
, pp. 803-826
-
-
Wanko, S.O.1
Telen, M.J.2
-
4
-
-
17344391561
-
Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease
-
Talano JA, Hillery CA, Gottsschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003;111:661-5.
-
(2003)
Pediatrics
, vol.111
, pp. 661-665
-
-
Talano, J.A.1
Hillery, C.A.2
Gottsschall, J.L.3
-
5
-
-
0036598527
-
Predicting the effect of transfusing only phenotype matched RBC's to patients with sickle cell disease: Theoretical and practical implications
-
Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype matched RBC's to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-91.
-
(2002)
Transfusion
, vol.42
, pp. 684-691
-
-
Castro, O.1
Sandler, S.G.2
Houston-Yu, P.3
Rana, S.4
-
6
-
-
0034858110
-
Prospective red blood cell phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial
-
Vichinsky EP, Luban NL, Wright E, et al. Prospective red blood cell phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-92.
-
(2001)
Transfusion
, vol.41
, pp. 1086-1092
-
-
Vichinsky, E.P.1
Luban, N.L.2
Wright, E.3
-
7
-
-
33750479247
-
-
Medical Director, Carter BloodCare at Childrens. Personal communication
-
Nizzi F. Medical Director, Carter BloodCare at Childrens. Personal communication. 2004.
-
(2004)
-
-
Nizzi, F.1
-
8
-
-
0027958085
-
Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease
-
Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994;83:1136-42.
-
(1994)
Blood
, vol.83
, pp. 1136-1142
-
-
Kim, H.C.1
Dugan, N.P.2
Silber, J.H.3
-
9
-
-
33750455345
-
-
Bruce C. McLeod, editor. Bethesda MD, AABB Press: 146-50
-
Bruce C. McLeod, editor. Therapeutic apheresis: a physicians handbook. 1st ed. Bethesda MD, AABB Press: 2005;120-7, 146-50.
-
(2005)
Therapeutic Apheresis: A Physicians Handbook. 1st Ed.
, pp. 120-127
-
-
-
10
-
-
0037414164
-
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment
-
Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-51.
-
(2003)
JAMA
, vol.289
, pp. 1645-1651
-
-
Steinberg, M.H.1
Barton, F.2
Castro, O.3
-
11
-
-
0031965089
-
Cerebrovascular accidents in sickle cell disease: Rates and risk factors
-
Ohene-Frempong K, Weiner SJ, Sleeper, LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
-
(1998)
Blood
, vol.91
, pp. 288-294
-
-
Ohene-Frempong, K.1
Weiner, S.J.2
Sleeper, L.A.3
-
12
-
-
4444309490
-
Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy
-
Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004;145:346-52.
-
(2004)
J Pediatr
, vol.145
, pp. 346-352
-
-
Ware, R.E.1
Zimmerman, S.A.2
Sylvestre, P.B.3
-
13
-
-
0026034335
-
High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
-
Wang WC, Kovnar EH, Tonkin IL, et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991;118:377-82.
-
(1991)
J Pediatr
, vol.118
, pp. 377-382
-
-
Wang, W.C.1
Kovnar, E.H.2
Tonkin, I.L.3
-
14
-
-
0026552537
-
A modified transfusion program for prevention of stroke in sickle cell disease
-
Cohen AR, Martin MB, Silber JH et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992;79:1657-61.
-
(1992)
Blood
, vol.79
, pp. 1657-1661
-
-
Cohen, A.R.1
Martin, M.B.2
Silber, J.H.3
-
15
-
-
0032474692
-
Prevention of a first stroke by transfusions in children with sickle-cell anemia and abnormal results on transcranial Doppler ultrasonography
-
Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle-cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
-
(1998)
N Engl J Med
, vol.339
, pp. 5-11
-
-
Adams, R.J.1
McKie, V.C.2
Hsu, L.3
-
16
-
-
0035659821
-
Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia
-
Miller St, Wright E, Abboud M, et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-9.
-
(2001)
J Pediatr
, vol.139
, pp. 785-789
-
-
Miller, St.1
Wright, E.2
Abboud, M.3
-
17
-
-
0033976044
-
Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism
-
Mantadakis E, Ewalt DH, Cavender JD, et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 2000;95:78-82.
-
(2000)
Blood
, vol.95
, pp. 78-82
-
-
Mantadakis, E.1
Ewalt, D.H.2
Cavender, J.D.3
-
18
-
-
0027737943
-
Association of sickle cell disease, priapism, exchange transfusion and neurological events: Aspen syndrome
-
Siegel JF, Rich MA, Brock WA. Association of sickle cell disease, priapism, exchange transfusion and neurological events: Aspen syndrome. J Urol 1993;150:1480-2.
-
(1993)
J Urol
, vol.150
, pp. 1480-1482
-
-
Siegel, J.F.1
Rich, M.A.2
Brock, W.A.3
-
19
-
-
0029027701
-
A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
-
Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995;333:206-13.
-
(1995)
N Engl J Med
, vol.333
, pp. 206-213
-
-
Vichinsky, E.P.1
Haberkern, C.M.2
Neumayr, L.3
-
20
-
-
20344384761
-
Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion
-
Fu T, Corrigan NJ, Quinn CT, Rogers ZR, Buchanan GR. Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion. Pediatr Blood Cancer 2005;45:43-7.
-
(2005)
Pediatr Blood Cancer
, vol.45
, pp. 43-47
-
-
Fu, T.1
Corrigan, N.J.2
Quinn, C.T.3
Rogers, Z.R.4
Buchanan, G.R.5
-
21
-
-
33745062600
-
-
Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. November
-
Package insert: Exjade (deferasirox). Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. November 2005.
-
(2005)
Package Insert: Exjade (Deferasirox)
-
-
|